A review of late-stage CNS drug candidates for the treatment of obesity.
Heal, D J
A review of late-stage CNS drug candidates for the treatment of obesity. [electronic resource] - International journal of obesity (2005) Jan 2013 - 107-17 p. digital
Publication Type: Journal Article; Review
1476-5497
10.1038/ijo.2012.26 doi
Anti-Obesity Agents--administration & dosage
Bupropion--pharmacology
Central Nervous System Stimulants--pharmacology
Drug Administration Schedule
Drug Approval
Drug Combinations
Drug Design
Drugs, Investigational
Female
Guidelines as Topic
Humans
Male
Naltrexone--pharmacology
Obesity--drug therapy
Patient Selection
Phentermine--pharmacology
Receptor, Serotonin, 5-HT2C--drug effects
Risk Factors
Risk Reduction Behavior
United Kingdom--epidemiology
A review of late-stage CNS drug candidates for the treatment of obesity. [electronic resource] - International journal of obesity (2005) Jan 2013 - 107-17 p. digital
Publication Type: Journal Article; Review
1476-5497
10.1038/ijo.2012.26 doi
Anti-Obesity Agents--administration & dosage
Bupropion--pharmacology
Central Nervous System Stimulants--pharmacology
Drug Administration Schedule
Drug Approval
Drug Combinations
Drug Design
Drugs, Investigational
Female
Guidelines as Topic
Humans
Male
Naltrexone--pharmacology
Obesity--drug therapy
Patient Selection
Phentermine--pharmacology
Receptor, Serotonin, 5-HT2C--drug effects
Risk Factors
Risk Reduction Behavior
United Kingdom--epidemiology